Sarah R White, CRNP | |
2250 E Market St, York, PA 17402-2857 | |
(717) 851-1566 | |
(717) 812-3950 |
Full Name | Sarah R White |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 25 Years |
Location | 2250 E Market St, York, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023030855 | NPI | - | NPPES |
PO1783547 | Other | PA | RAILROAD MEDICARE |
102646588 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | TP006196B (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Milton S Hershey Medical Center | Hershey, PA | Hospital |
St Joseph Medical Center | Reading, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Penn State Health Community Medical Group Llc | 8729351077 | 646 |
News Archive
"The regional meeting to scale up collaborative TB/HIV activities in Africa kicked off in Maputo last week with presentations scheduled for 14 African country representatives to share progress and challenges in confronting TB/HIV co-infection in the most highly impacted region of the world," the Center for Global Health Policy's "Science Speaks" blog reports.
Combined treatment with a drug that mimics the action of a gut hormone and basal insulin is more effective at improving blood sugar control than other anti-diabetic treatments, with similar rates of hypoglycaemia (dangerously low blood sugar levels) and greater weight loss, a systematic review and meta-analysis published in The Lancet shows.
Incyte Corporation (Nasdaq: INCY) announced results from a 12-week, placebo-controlled, dose-escalationin involving 60 patients with active rheumatoid arthritis for its proprietary oral JAK1 inhibitor.
Urgently needed capital should become more accessible to Ontario's bioscience companies and help create jobs in the biotechnology sector, thanks to Ontario's 2010 budget. An announced increase in the budget of the Ministry of Research and Innovation coupled with anticipated adjustments to existing funding programs designed to encourage research and innovation are applauded by Ontario Bioscience Industry Organization (OBIO).
› Verified 7 days ago
Entity Name | Wellspan Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
"The regional meeting to scale up collaborative TB/HIV activities in Africa kicked off in Maputo last week with presentations scheduled for 14 African country representatives to share progress and challenges in confronting TB/HIV co-infection in the most highly impacted region of the world," the Center for Global Health Policy's "Science Speaks" blog reports.
Combined treatment with a drug that mimics the action of a gut hormone and basal insulin is more effective at improving blood sugar control than other anti-diabetic treatments, with similar rates of hypoglycaemia (dangerously low blood sugar levels) and greater weight loss, a systematic review and meta-analysis published in The Lancet shows.
Incyte Corporation (Nasdaq: INCY) announced results from a 12-week, placebo-controlled, dose-escalationin involving 60 patients with active rheumatoid arthritis for its proprietary oral JAK1 inhibitor.
Urgently needed capital should become more accessible to Ontario's bioscience companies and help create jobs in the biotechnology sector, thanks to Ontario's 2010 budget. An announced increase in the budget of the Ministry of Research and Innovation coupled with anticipated adjustments to existing funding programs designed to encourage research and innovation are applauded by Ontario Bioscience Industry Organization (OBIO).
› Verified 7 days ago
Entity Name | Penn State Health Community Medical Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861988644 PECOS PAC ID: 8729351077 Enrollment ID: O20170907002279 |
News Archive
"The regional meeting to scale up collaborative TB/HIV activities in Africa kicked off in Maputo last week with presentations scheduled for 14 African country representatives to share progress and challenges in confronting TB/HIV co-infection in the most highly impacted region of the world," the Center for Global Health Policy's "Science Speaks" blog reports.
Combined treatment with a drug that mimics the action of a gut hormone and basal insulin is more effective at improving blood sugar control than other anti-diabetic treatments, with similar rates of hypoglycaemia (dangerously low blood sugar levels) and greater weight loss, a systematic review and meta-analysis published in The Lancet shows.
Incyte Corporation (Nasdaq: INCY) announced results from a 12-week, placebo-controlled, dose-escalationin involving 60 patients with active rheumatoid arthritis for its proprietary oral JAK1 inhibitor.
Urgently needed capital should become more accessible to Ontario's bioscience companies and help create jobs in the biotechnology sector, thanks to Ontario's 2010 budget. An announced increase in the budget of the Ministry of Research and Innovation coupled with anticipated adjustments to existing funding programs designed to encourage research and innovation are applauded by Ontario Bioscience Industry Organization (OBIO).
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Sarah R White, CRNP 3421 Concord Rd, York, PA 17402-9001 Ph: (717) 851-1566 | Sarah R White, CRNP 2250 E Market St, York, PA 17402-2857 Ph: (717) 851-1566 |
News Archive
"The regional meeting to scale up collaborative TB/HIV activities in Africa kicked off in Maputo last week with presentations scheduled for 14 African country representatives to share progress and challenges in confronting TB/HIV co-infection in the most highly impacted region of the world," the Center for Global Health Policy's "Science Speaks" blog reports.
Combined treatment with a drug that mimics the action of a gut hormone and basal insulin is more effective at improving blood sugar control than other anti-diabetic treatments, with similar rates of hypoglycaemia (dangerously low blood sugar levels) and greater weight loss, a systematic review and meta-analysis published in The Lancet shows.
Incyte Corporation (Nasdaq: INCY) announced results from a 12-week, placebo-controlled, dose-escalationin involving 60 patients with active rheumatoid arthritis for its proprietary oral JAK1 inhibitor.
Urgently needed capital should become more accessible to Ontario's bioscience companies and help create jobs in the biotechnology sector, thanks to Ontario's 2010 budget. An announced increase in the budget of the Ministry of Research and Innovation coupled with anticipated adjustments to existing funding programs designed to encourage research and innovation are applauded by Ontario Bioscience Industry Organization (OBIO).
› Verified 7 days ago
Mrs. Anuradha Sharma, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1001 S George St, 3rd Floor, York, PA 17403 Phone: 717-851-4005 Fax: 717-812-2495 | |
Ms. Nicole Marie Campanella, CNM Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 116 S George St, York, PA 17401 Phone: 717-845-8617 | |
Ms. Carleen Ann Myers, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1600 6th Ave, Ste 117, York, PA 17403 Phone: 717-840-9885 Fax: 717-840-9313 | |
Mr. Dennis B. Macdougall, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1855 Powder Mill Rd, York, PA 17402 Phone: 717-848-4800 Fax: 717-741-9867 | |
Kayla Nicole Taylor, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1695 Roosevelt Ave Ste B, York, PA 17408 Phone: 717-851-5503 Fax: 717-798-3510 | |
Shelly Jean Levinstein, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1920 Queenswood Dr, Suite 200, York, PA 17403 Phone: 717-747-3566 Fax: 717-747-3678 |